A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis
一项针对原发性胆汁性胆管炎的安慰剂对照 II 期临床试验，研究了抗人趋化因子单克隆抗体 E6011 的疗效。
期刊:Journal of Translational Autoimmunity
影响因子:3.6
doi:10.1016/j.jtauto.2025.100283
Tanaka, Atsushi; Abe, Masanori; Namisaki, Tadashi; Shimoda, Shinji; Zeniya, Mikio; Ido, Akio; Yoshiji, Hitoshi; Ohira, Hiromasa; Harada, Kenichi; Kakuda, Yuko; Umeda, Atsushi; Kamiya, Yuki; Higashine, Yukari; Hojo, Seiichiro; Imai, Toshio; Kawano, Tetsu; Nakanuma, Yasuni; Tsubouchi, Hirohito
